Priya B K, Aishwarya A, Manickavasagam R, Susila R
Siddha Clinical Research Unit, Central Council for Research in Siddha, Safdarjung Hospital, New Delhi, India.
Siddha Central Research Institute, Central Council for Research in Siddha, Arumbakkam, Chennai, Tamil Nadu, India.
J Family Med Prim Care. 2022 Jul;11(7):4062-4066. doi: 10.4103/jfmpc.jfmpc_1953_21. Epub 2022 Jul 22.
Renaissance in acceptance of the system of medicine in all over India happened during the current scenario of coronavirus disease-2019 (COVID-19) pandemic. The classical texts of medicine contain descriptions of the symptoms of COVID-19 as a syndrome like definition that may be correlated with . A 49-year-old female residing at New Delhi who got COVID-19 positive with comorbidity of hypothyroidism treated successfully using an integrative treatment plan (Siddha and Allopathic) as per Government-mandated COVID-19 treatment guidelines. The patient developed symptoms such as fever, sore throat, cold, cough with expectoration, difficulty in breathing, chest congestion, and body ache. Initially the patient took Western Medicine (WM) for five days but the symptoms did not subside. After five days an integrated treatment including medicine (Internal and external medicines) initiated at In Patient ward, Safdarjung Hospital. The health of the patient improved within 3 days and all her symptoms got relieved within 10 days. After completion of treatment, she tested reverse transcription - polymerase chain reaction (RT-PCR) and it was negative on 14 day. Another patient who was admitted with her got COVID-19 positive turned negative only after 30 days as she missed the integrative medicine by probability. The reported case had a prospective follow-up for six months and found to be free of post-COVID complications. Since, this case report based on a single case which shows a positive outcome is incapable of generalizing the conclusion. Further suitable clinical trials need to be conducted to assess its efficacy. The status of the summary is reported as per CAse REport (CARE) guidelines.
在2019年冠状病毒病(COVID-19)大流行的当前情况下,印度各地对医学体系的接受度迎来了复兴。医学经典文献中包含了对COVID-19症状的描述,其作为一种综合征的定义可能与之相关。一名居住在新德里的49岁女性,新冠病毒检测呈阳性,同时患有甲状腺功能减退症,按照政府规定的COVID-19治疗指南,采用综合治疗方案(悉达医学和西医)成功治愈。患者出现了发热、喉咙痛、感冒、咳痰咳嗽、呼吸困难、胸部充血和身体疼痛等症状。起初,患者服用了五天西药,但症状并未缓解。五天后,在萨夫达容医院的住院病房开始了包括悉达医学(内服和外用药)在内的综合治疗。患者的健康状况在3天内有所改善,所有症状在10天内得到缓解。治疗结束后,她进行了逆转录-聚合酶链反应(RT-PCR)检测,14天时结果为阴性。另一名与她一同入院的患者,新冠病毒检测呈阳性,由于可能错过了综合药物治疗,直到30天后才转阴。报告的该病例进行了为期六个月的前瞻性随访,发现没有COVID-19后并发症。由于本病例报告基于一个显示出积极结果的单一病例,无法推广该结论。需要进一步开展合适的临床试验来评估其疗效。根据病例报告(CARE)指南报告了总结情况。